Apimeds Pharmaceuticals US (APUS) IPO Filing
Apimeds Pharmaceuticals US (APUS) has filed for an initial public offering (IPO) of 3,333,334 shares, with a projected price range of $3 to $4 per share.
Apimeds Pharmaceuticals US Files for 3.33M Share IPO at $3-$4/sh
Greed and Fear Index
Note: The data is for reference only.
Greed
63
Comments (0)